BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26996518)

  • 1. Concise review: programming human pluripotent stem cells into blood.
    Easterbrook J; Fidanza A; Forrester LM
    Br J Haematol; 2016 Jun; 173(5):671-9. PubMed ID: 26996518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
    Sugimura R
    Methods Mol Biol; 2019; 2005():37-41. PubMed ID: 31175644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
    Hwang Y; Broxmeyer HE; Lee MR
    Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic developmental potential of human pluripotent stem cell lines.
    Tesařová L; Simara P; Stejskal S; Koutná I
    Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells.
    Yang CT; Ma R; Axton RA; Jackson M; Taylor AH; Fidanza A; Marenah L; Frayne J; Mountford JC; Forrester LM
    Stem Cells; 2017 Apr; 35(4):886-897. PubMed ID: 28026072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematopoietic stem and progenitor cells from human pluripotent stem cells.
    Sugimura R; Jha DK; Han A; Soria-Valles C; da Rocha EL; Lu YF; Goettel JA; Serrao E; Rowe RG; Malleshaiah M; Wong I; Sousa P; Zhu TN; Ditadi A; Keller G; Engelman AN; Snapper SB; Doulatov S; Daley GQ
    Nature; 2017 May; 545(7655):432-438. PubMed ID: 28514439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making HSCs in vitro: don't forget the hemogenic endothelium.
    Blaser BW; Zon LI
    Blood; 2018 Sep; 132(13):1372-1378. PubMed ID: 30089629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
    Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
    Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells.
    Liu S; Xu Y; Zhou Z; Feng B; Huang H
    Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects and challenges of induced pluripotent stem cells as a source of hematopoietic stem cells.
    van Bekkum DW; Mikkers HM
    Ann N Y Acad Sci; 2012 Aug; 1266():179-88. PubMed ID: 22901269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Phondeechareon T; Wattanapanitch M; U-Pratya Y; Damkham C; Klincumhom N; Lorthongpanich C; Kheolamai P; Laowtammathron C; Issaragrisil S
    Ann Hematol; 2016 Oct; 95(10):1617-25. PubMed ID: 27465155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-induced pluripotent stem cell-derived blood products: state of the art and future directions.
    Hansen M; von Lindern M; van den Akker E; Varga E
    FEBS Lett; 2019 Dec; 593(23):3288-3303. PubMed ID: 31520530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematopoietic stem cell reprogramming and the hope for a universal blood product.
    Barcia Durán JG; Lis R; Rafii S
    FEBS Lett; 2019 Dec; 593(23):3253-3265. PubMed ID: 31725897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles.
    Panopoulos AD; Belmonte JC
    Curr Opin Hematol; 2012 Jul; 19(4):256-60. PubMed ID: 22555392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cells are pluripotent and not just "hematopoietic".
    Ogawa M; LaRue AC; Mehrotra M
    Blood Cells Mol Dis; 2013 Jun; 51(1):3-8. PubMed ID: 23453528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of mature hematopoietic cells from human pluripotent stem cells.
    Togarrati PP; Suknuntha K
    Int J Hematol; 2012 Jun; 95(6):617-23. PubMed ID: 22648826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.
    Ferreira AF; Calin GA; Picanço-Castro V; Kashima S; Covas DT; de Castro FA
    J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29467236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
    Hexum MK; Tian X; Kaufman DS
    Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive Erythropoiesis from Pluripotent Stem Cells: Recent Advances and Perspectives.
    Demirci S; Tisdale JF
    Adv Exp Med Biol; 2018; 1107():1-13. PubMed ID: 29876866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.